| Name | Cvs Pharmacy #05301 |
|---|---|
| Organization Name | Montana Cvs Pharmacy Llc |
| Location | 1311 Grand Ave, Billings, Montana 59102 |
| Type | Pharmacy |
| Phone | (406) 259-7034 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The findings are based on almost 26,000 patients who had coronary artery bypass surgery (CABG) for the first time between1997 to 2005, in the north west of England.
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.
At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.
A team of Canadian researchers probed 45 pediatric clinicians to learn about possible indicators that could help identify infants with chronic pain and provide guidance on how to differentiate chronic pain from lingering pain caused by medical procedures.
› Verified 9 days ago
| NPI Number | 1023102423 |
| Organization Name | SNYDERS WESTERN |
| Doing Business As | SNYDER DRUG EMPORIUM |
| Type | Pharmacy |
| Address | 1311 Grand Ave, Billings, MT 59102 |
| Phone Number | 406-259-7034 |
News Archive
The findings are based on almost 26,000 patients who had coronary artery bypass surgery (CABG) for the first time between1997 to 2005, in the north west of England.
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.
At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.
A team of Canadian researchers probed 45 pediatric clinicians to learn about possible indicators that could help identify infants with chronic pain and provide guidance on how to differentiate chronic pain from lingering pain caused by medical procedures.
› Verified 9 days ago
| NPI Number | 1750551966 |
| Organization Name | MONTANA CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY# 05301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1311 Grand Ave, Billings, MT 59102 |
| Phone Number | 406-259-7034 |
News Archive
The findings are based on almost 26,000 patients who had coronary artery bypass surgery (CABG) for the first time between1997 to 2005, in the north west of England.
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.
At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.
A team of Canadian researchers probed 45 pediatric clinicians to learn about possible indicators that could help identify infants with chronic pain and provide guidance on how to differentiate chronic pain from lingering pain caused by medical procedures.
› Verified 9 days ago
News Archive
The findings are based on almost 26,000 patients who had coronary artery bypass surgery (CABG) for the first time between1997 to 2005, in the north west of England.
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.
At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.
A team of Canadian researchers probed 45 pediatric clinicians to learn about possible indicators that could help identify infants with chronic pain and provide guidance on how to differentiate chronic pain from lingering pain caused by medical procedures.
› Verified 9 days ago
Cvs Pharmacy #08623 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2402 Grand Ave, Billings, Montana 59102 Phone: (406) 252-6334 | |
Cvs Pharmacy #05301 Type: Pharmacy Location: 1311 Grand Ave, Billings, Montana 59102 Phone: (406) 259-7034 | |
Cvs Pharmacy #05302 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 425 Main St, Billings, Montana 59105 Phone: (406) 259-7861 | |
Cvs Pharmacy 08944 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 617 Central Ave, Billings, Montana 59102 Phone: (406) 256-4924 | |
Cvs Pharmacy #16037 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2601 Central Ave, Billings, Montana 59102 Phone: (406) 652-2263 |